Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Eloralintide (LY3841136): A novel selective amylin receptor agonist designed to enhance satiety, slow gastric emptying, and reduce caloric intake through amylin pathway signaling
Among these, metformin and semaglutide have emerged as leading candidates and are currently being evaluated in clinical trials for their potential to prevent cognitive decline associated with AD 10,11,12
Why it might have failed The negative results may have several explanations
This is speculative but mechanistically plausible
US$ 25.39
US$ 29.15
US$ 29.74
US$ 25.71
US$ 24.98
